As of Jul 31
| +0.29 / +1.91%|
The 5 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 19.00, with a high estimate of 22.00 and a low estimate of 18.00. The median estimate represents a +22.58% increase from the last price of 15.50.
The current consensus among 5 polled investment analysts is to Buy stock in AngioDynamics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.